Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

380 ARTÍCULOS , VIENDO DEL 76 AL 90

Bilateral brown plaques behind the ears

Mattessich S, Aubert P, Rees A.

Cutis. 2018 Oct;102(4):E1-E3.

Atypical presentation of progressive young onset dementia

Elhusein B, Radwan A, Khairi A, Ahmed M.

BMJ Case Rep. 2018 Dec 3;11(1):bcr2018225754. doi: 10.1136/bcr-2018-225754.

High blood pressure, Alzheimer disease and antihypertensive treatment

Marfany A, Sierra C, Camafort M, Doménech M, Coca A.

Panminerva Med. 2018 Mar;60(1):8-16. doi: 10.23736/S0031-0808.18.03360-8. Epub 2018 Jan 25.

Intranasal insulin in Alzheimer's dementia or mild cognitive impairment: a systematic review

Avgerinos KI, Kalaitzidis G, Malli A, Kalaitzoglou D, Myserlis PG, Lioutas VA.

J Neurol. 2018 Jul;265(7):1497-1510. doi: 10.1007/s00415-018-8768-0. Epub 2018 Feb 1.

Environmental and Dietary Exposure to Copper and Its Cellular Mechanisms Linking to Alzheimer's Disease

Hsu HW, Bondy SC, Kitazawa M.

Toxicol Sci. 2018 Jun 1;163(2):338-345. doi: 10.1093/toxsci/kfy025.

Abnormalities of Resting State Cortical EEG Rhythms in Subjects with Mild Cognitive Impairment Due to Alzheimer's and Lewy Body Diseases

Babiloni C, Del Percio C, Lizio R, Noce G, Lopez S, Soricelli A, Ferri R, Pascarelli MT, Catania V, Nobili F, Arnaldi D, Famà F, Aarsland D, Orzi F, Buttinelli C, Giubilei F, Onofrj M, Stocchi F, Vacca L, Stirpe P, Fuhr P, Gschwandtner U, Ransmayr G, Garn H, Fraioli L, Pievani M, Frisoni GB, D'Antonio F, De Lena C, Güntekin B, Hanoğlu L, Başar E, Yener G, Emek-Savaş DD, Triggiani AI, Franciotti R, Taylor JP, De Pandis MF, Bonanni L.

J Alzheimers Dis. 2018;62(1):247-268. doi: 10.3233/JAD-170703.

Reliability of coded data to identify earliest indications of cognitive decline, cognitive evaluation and Alzheimer's disease diagnosis: a pilot study in England

Dell'Agnello G, Desai U, Kirson NY, Wen J, Meiselbach MK, Reed CC, Belger M, Lenox-Smith A, Martinez C, Rasmussen J.

BMJ Open. 2018 Mar 22;8(3):e019684. doi: 10.1136/bmjopen-2017-019684.

ApoE4 May be a Promising Target for Treatment of Coronary Heart Disease and Alzheimer's Disease

Chen W, Jin F, Cao G, Mei R, Wang Y, Long P, Wang X, Ge W.

Curr Drug Targets. 2018;19(9):1038-1044. doi: 10.2174/1389450119666180406112050.

High level of Mn in brain is a risk for Alzheimer disease

Yu Q, Zhou YZ.

Sheng Li Xue Bao. 2018 Apr 25;70(2):193-200.

Use of Flutemetamol F 18-Labeled Positron Emission Tomography and Other Biomarkers to Assess Risk of Clinical Progression in Patients With Amnestic Mild Cognitive Impairment

Wolk DA, Sadowsky C, Safirstein B, Rinne JO, Duara R, Perry R, Agronin M, Gamez J, Shi J, Ivanoiu A, Minthon L, Walker Z, Hasselbalch S, Holmes C, Sabbagh M, Albert M, Fleisher A, Loughlin P, Triau E, Frey K, Høgh P, Bozoki A, Bullock R, Salmon E, Farrar G, Buckley CJ, Zanette M, Sherwin PF, Cherubini A, Inglis F.

JAMA Neurol. 2018 Sep 1;75(9):1114-1123. doi: 10.1001/jamaneurol.2018.0894.

Biomarkers of agitation and aggression in Alzheimer's disease: A systematic review

Ruthirakuhan M, Lanctôt KL, Di Scipio M, Ahmed M, Herrmann N.

Alzheimers Dement. 2018 Oct;14(10):1344-1376. doi: 10.1016/j.jalz.2018.04.013. Epub 2018 Jun 23.

Sex Differences in the Neuropsychiatric Symptoms of Patients With Alzheimer's Disease

Tao Y, Peters ME, Drye LT, Devanand DP, Mintzer JE, Pollock BG, Porsteinsson AP, Rosenberg PB, Schneider LS, Shade DM, Weintraub D, Yesavage J, Lyketsos CG, Munro CA.

Am J Alzheimers Dis Other Demen. 2018 Nov;33(7):450-457. doi: 10.1177/1533317518783278. Epub 2018 Jul 3.

Sex differences in Alzheimer disease - the gateway to precision medicine

Ferretti MT, Iulita MF, Cavedo E, Chiesa PA, Schumacher Dimech A, Santuccione Chadha A, Baracchi F, Girouard H, Misoch S, Giacobini E, Depypere H, Hampel H; Women’s Brain Project and the Alzheimer Precision Medicine Initiative.

Nat Rev Neurol. 2018 Aug;14(8):457-469. doi: 10.1038/s41582-018-0032-9.

Low expression of aging-related NRXN3 is associated with Alzheimer disease: A systematic review and meta-analysis

Zheng JJ, Li WX, Liu JQ, Guo YC, Wang Q, Li GH, Dai SX, Huang JF.

Medicine (Baltimore). 2018 Jul;97(28):e11343. doi: 10.1097/MD.0000000000011343.

18F-FDG PET for Prediction of Conversion to Alzheimer's Disease Dementia in People with Mild Cognitive Impairment: An Updated Systematic Review of Test Accuracy

Smailagic N, Lafortune L, Kelly S, Hyde C, Brayne C.

J Alzheimers Dis. 2018;64(4):1175-1194. doi: 10.3233/JAD-171125.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias